Clinical Trials
3 trialsNCT05469490 2022-09-30
Safety of Navoximod and NLG802 With Stereotactic Body Radiotherapy (SBRT) Treatment of Advanced Solid Tumors
University of Pittsburgh
Phase 1 Withdrawn
NCT02471846 2019-10-22
A Study of GDC-0919 and Atezolizumab Combination Treatment in Participants With Locally Advanced or Metastatic Solid Tumors
Genentech, Inc.
Phase 1 Completed
NCT02048709 2017-02-06
Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Advanced Solid Tumors
Genentech, Inc.
Phase 1 Completed